# Nektar Therapeutics: Form 8-K, filed Jun 6, 2024

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2024-06-06
- Accepted by EDGAR: Jun 6, 2024, 16:05 ET
- Period: 2024-06-05
- Accession: 0001213900-24-050365
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000121390024050365/ea0207441-8k_nektar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000121390024050365/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000121390024050365/ea0207441-8k_nektar.htm

Filed Jun 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-050365. Last ingested by Listed: Nov 14, 2026, 10:52 ET. No prices; not investment advice.